Source: San Jose Mercury News
Posted: February 24, 2008 01:39:43 AM PST
Summary:
The San Jose Mercury News reports that Geron Corporation, a biotechnology company in the field of stem cell research, announced that its embryonic stem cell therapy for treating spinal cord injuries is ready for tests in humans with spinal cord injuries:
"After 13 years of research costing more than $150 million, Geron says it is finally ready to conduct an unprecedented test in people with a treatment made from one of the most controversial substances in science. Using human embryonic stem cells, the Menlo Park company has developed a therapy that enables paralyzed rats to walk and that it claims shows no dangerous side effects in experiments with about 2,000 animals. Others also are studying such cells for medical uses, including Stanford University scientists, who last week said they had used them to help stroke-disabled lab rats walk better. But none are as close to seeking permission for human tests as Geron, whose treatment is for spinal injuries."
